K Hermansen, M Davies, T Derezinski, G Martinez … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—At 24 weeks, A1C had decreased by 1.8 and 1.9% (from 8.6 to 6.8 and from 8.5
to 6.6%) for detemir and NPH, respectively (NS). In both groups, 70% of participants achieved
an A1C ≤7.0%, but the proportion achieving this without hypoglycemia was higher with ... Cited by 225 - Related articles - BL Direct - All 9 versions
T Haak, A Tiengo, E Draeger, M Suntum, W … - Diabetes Obesity and …, 2005 - fe-inzichten.nl Aim: The aim of this study was to compare the efficacy and safety of a basal-bolus insulin regimen
comprising either insulin detemir or neural protamine hagedorn (NPH) insulin in combination
with mealtime insulin aspart in patients with type 2 diabetes. Methods: This was a ... Cited by 193 - Related articles - View as HTML - All 5 versions
K Rašlová, M Bogoev, I Raz, G Leth, MA Gall, N … - Diabetes research and …, 2004 - Elsevier This trial compared the efficacy and safety of basal-bolus therapy using either the soluble basal
insulin analogue insulin detemir (IDet) in combination with meal-time rapid-acting analogue
insulin aspart (IAsp), or NPH insulin (NPH) in combination with meal-time regular human ... Cited by 160 - Related articles - All 8 versions
P Home, P Bartley, D Russell-Jones, H Hanaire- … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—With both insulin detemir groups, clinic fasting plasma glucose was lower than with
NPH insulin (IDet 12h vs. NPH, −1.5 mmol/l [95% CI −2.51 to −0.48], P = 0.004; IDet morn+bed
vs. NPH, −2.3 mmol/l (−3.32 to −1.29), P < 0.001), as was self-measured prebreakfast ... Cited by 153 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org J Plank, M Bodenlenz, F Sinner, C Magnes, E … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Duration of action for insulin detemir was dose dependent and varied from 5.7, to
12.1, to 19.9, to 22.7, to 23.2 h for 0.1, 0.2, 0.4, 0.8, and 1.6 units/kg, respectively. Interpolation
of the dose-response relationships for AUC GIR (area under the glucose infusion rate ... Cited by 129 - Related articles - All 9 versions
I De Leeuw, P Vague, JL Selam, S Skeie, … - Diabetes Obesity …, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 130 - Related articles - All 5 versions
D Russell-Jones, R Simpson, B Hylleberg, E Draeger, J … - Clinical therapeutics, 2004 - Elsevier Methods: This was a 6-month, prospective, randomized, open-label, controlled, parallel-group
trial conducted at 92 sites in Europe and Australia. The trial population included men and women
with type 1 DM for at least 1 year aged ≥ 18 years with glycosylated hemoglobin (HbA 1c ... Cited by 122 - Related articles - All 4 versions
TR Pieber, E Draeger, A Kristensen, V Grill - Diabetic Medicine, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 89 - Related articles - All 4 versions
E Standl, H Lang, A Roberts - Diabetes technology & therapeutics, 2004 - liebertonline.com EBERHARD STANDL, MD,1 HANNE LANG, M.Sc.,2 and ANTHONY ROBERTS, MD3 ...
Background: This trial compared the long-term safety and efficacy of the basal insulin prepa-
rations, insulin detemir and NPH insulin, in basal-bolus therapy for patients with type 1 ... Cited by 85 - Related articles - BL Direct - All 3 versions
O Klein, J Lynge, L Endahl, B Damholt, L … - Diabetes Obes …, 2007 - interscience.wiley.com Methods: Twenty-seven insulin-treated men with type 2 diabetes [body mass index 30.8 ± 2.6
kg/m 2 (mean ± sd), haemoglobin A 1c 7.6 ± 1.1%] were enrolled in this randomized,
double-blind trial and participated in six euglycaemic glucose clamp experiments [target ... Cited by 71 - Related articles - All 4 versions
